Back

The prognostic implications of serum NT-pro B-type Natriuretic Peptide (NT-proBNP) in emergency medical admissions.

30 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Myles Mckittrick

University Hospital Limerick, Limerick (Ireland)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Tezuka (Tokyo, JP)
Abstract
Presentation thumbnail
Ms P. Rodriguez Montes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Doctor C. Neerapattanakul (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Doctor T. Nishikimi (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods

The Event

Event poster

ESC Congress 2025

30 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of NT-proBNP and cardiac troponin levels in ambulatory patients with congestive heart failure - Insight from NHANES.
thumbnail
Congress Presentation
NT-proBNP at day 4 of hospitalization: a single prognostic marker for prediction of both in-hospital and post-discharge outcomes in acute heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Risk stratification guided by NT-proBNP after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources